MARKET

ZLAB

ZLAB

Zai Lab Limited
NASDAQ
15.66
+0.54
+3.57%
Closed 16:00 04/24 EDT
OPEN
15.89
PREV CLOSE
15.12
HIGH
16.12
LOW
15.49
VOLUME
434.00K
TURNOVER
0
52 WEEK HIGH
39.50
52 WEEK LOW
13.48
MARKET CAP
1.55B
P/E (TTM)
-4.5226
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at ZLAB last week (0415-0419)?
Weekly Report · 2d ago
Zai Lab files automatic ordinary shares offering
Seeking Alpha · 5d ago
ClearBridge International Growth ACWI Ex-US Strategy Q1 2024 Commentary
Seeking Alpha · 5d ago
A Risky Bet: Zai Lab's Uncertain Future
Seeking Alpha · 04/16 21:08
Weekly Report: what happened at ZLAB last week (0408-0412)?
Weekly Report · 04/15 11:20
Zai Lab to Announce First Quarter 2024 Financial Results and Recent Corporate Updates on May 8, 2024
Zai Lab Limited will report financial results for the first quarter of 2024 and recent corporate updates on May 8, 2024. The Company will host a live conference call and webcast on Thursday, May 9, 2024, at 8:00 a.m. ET. Participants must register in advance of the conference call.
Barchart · 04/15 06:30
ZAI LAB LTD - EXECUTIVES AGREE NOT TO SELL SHARES IN 2024
Reuters · 04/11 11:30
Zai Lab Statement on Executive Management Team’s Agreement on Share Activities
Executive Officers of Zai Lab Limited say they do not anticipate selling any shares in the company through the remainder of 2024. Zai lab is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the U.S. The Executive Officers have agreed to stay on the board through 2024.
Barchart · 04/11 06:30
More
About ZLAB
Zai Lab Ltd is a holding company mainly engaged in the biopharmaceutical field. The Company is focused on discovering or licensing, developing and commercializing proprietary therapeutics that address areas of large unmet medical need in the China market, including oncology, autoimmune and infectious diseases fields. The Company has a broad pipeline of proprietary drug candidates that range from discovery stage to late-stage clinical programs. These include Niraparib (ZL-2306), ZL-2103, ZL-1101 and others.

Webull offers Zai Lab Ltd - ADR stock information, including NASDAQ: ZLAB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZLAB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZLAB stock methods without spending real money on the virtual paper trading platform.